Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Continuous Gastrocnemius plane block with ropivacaine
The First People's Hospital of Lianyungang
Foot Ankle Injuries
1 trial -
Ropivacaine HCL
Atrium Therapeutics
Renal Carcinoma
1 trial -
SODIUM CHLORIDE, ROPIVACAINE
Pari Pharma GmbH
Cancer surgery
1 trial -
Ropivacaine injection
United Therapeutics Europe Ltd
Stress Disorders, Post-Traumatic
2 trials -
0.3% ropivacaine and 50 ΞΌg dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Free Flap Reconstruction
1 trial -
0.33% ropivacaine 250ml
Guangzhou General Hospital of Guangzhou Military Command
Pain
1 trial -
MgSO4 plus Ropivacaine
Hospital Authority, Hong Kong
Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block
1 trial -
ROPIVACAINE , SODIUM CHLORIDE
Disc Medicine
Urolithiasis
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Radius Fractures
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
End Stage Renal Disease (ESRD)
1 trial -
Ropivacaine B. Braun 10 mg/ml injektionsvΓ€tska, lΓΆsning
The George Institute
lumbar arthrodesis
1 trial -
S-ketamine & Ropivacaine
The First People's Hospital of Lianyungang
Postoperative Analgesia
1 trial -
SODIUM CHLORIDE, ROPIVACAINE HYDROCHLORIDE
Disc Medicine
Total Hip Arthroplasty / THA
1 trial -
Triamcinolone acetonide-Ketorolac-Ropivacaine
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
preoperative 0.5% ropivacaine hydrochloride preoperative
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Pain
1 trial -
ropivacaine
The First People's Hospital of Lianyungang
Injury of Upper Limb
1 trial -
Dexmedetomidine ropivacaine
The First People's Hospital of Lianyungang
Pharmacological Action
1 trial -
Hydromorphone combined with ropivacaine
Second Hospital of Jilin University
Inguinal Hernia
1 trial -
Ropivacaine
Zealand Pharma A/S
Pain, Postoperative
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Liver Diseases
1 trial -
Ropivacaine
Lei Xiaoming
Cystic Adenomatoid Malformation of Lung, Congenital
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Surgery
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Femoral Fracture
1 trial -
Ropivacaine Hydrochloride 10 MG/ML [Naropin]
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources